Gabe SM et al. |
The effect of tacrolimus (FK506) on intestinal barrier function and cellular energy production in humans. |
1998 |
Gastroenterology |
pmid:9649460
|
Gruessner RW et al. |
Suggested guidelines for the use of tacrolimus in pancreas/kidney transplantation. |
1998 |
Clin Transplant |
pmid:9642520
|
Kuwata T et al. |
A role of calcineurin in coreceptor regulation during differentiation of Cd4+Cd8+ T cells. |
1998 |
Biochem. Biophys. Res. Commun. |
pmid:9642110
|
Murray M et al. |
Comparison of tacrolimus absorption in transplant patients receiving continuous versus interrupted enteral nutritional feeding. |
1998 |
Ann Pharmacother |
pmid:9640479
|
Morris-Stiff G and Jurewicz WA |
Single centre experience with mycophenolate mofetil for refractory rejection in cadaveric renal transplantation. |
1998 |
Transpl. Int. |
pmid:9638849
|
Takahara S et al. |
A comparative study of FK506 granules and capsules in renal transplant recipients. |
1998 |
Transpl. Int. |
pmid:9638846
|
Abraham RT |
Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. |
1998 |
Curr. Opin. Immunol. |
pmid:9638370
|
Baldari CT et al. |
NF-AT-luciferase reporter T cell lines as tools to screen immunosuppressive drugs. |
1998 |
Biologicals |
pmid:9637743
|
Resch K and Szamel M |
Molecular mechanisms of the immunosuppressive action of cyclosporin A. |
1997 Sep-Oct |
Int. J. Immunopharmacol. |
pmid:9637358
|
Schneeberger H et al. |
Tacrolimus as a primary immunosuppressive therapy in cadaveric renal transplantation: five years' experience at a single center. |
1998 |
Transplant. Proc. |
pmid:9636642
|
Gerber DA et al. |
Immunosuppressive agents: recent developments in molecular action and clinical application. |
1998 |
Transplant. Proc. |
pmid:9636637
|
Goulet O et al. |
Small bowel transplantation alone or with the liver in children: changes by using FK506. |
1998 |
Transplant. Proc. |
pmid:9636636
|
Stratta RJ |
Late acute rejection episodes after vascularized pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636633
|
Gruessner RW |
Antibody induction therapy in pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636632
|
Burke GW et al. |
Use of tacrolimus and mycophenolate mofetil for pancreas-kidney transplantation with or without OKT3 induction. |
1998 |
Transplant. Proc. |
pmid:9636627
|
Peddi VR et al. |
Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636626
|
Bruce DS et al. |
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636625
|
Ciancio G et al. |
Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636624
|
Schulz T et al. |
Tacrolimus/mycophenolate mofetil/steroid-based immunosuppression after pancreas-kidney transplantation with single shot antithymocyte globulin. |
1998 |
Transplant. Proc. |
pmid:9636623
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|